Camp4 Therapeutics Corporation
CAMP
$5.31
$0.030.57%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/4/2025
-
Insider Monkey
3/4/2025
-
Insider Monkey
2/6/2025
-
Globe Newswire
1/13/2025
-
Globe Newswire
1/7/2025
-
The Fly
1/7/2025
-
Globe Newswire
12/26/2024
-
ETF Channel
12/10/2024
-
TipRanks Financial Blog
12/10/2024
-
The Fly
12/10/2024
-
Globe Newswire
12/6/2024
-
TipRanks Financial Blog
12/5/2024
-
TipRanks Financial Blog
12/5/2024
-
The Fly
12/5/2024
-
TipRanks Financial Blog
12/5/2024
-
The Fly
12/2/2024
-
Globe Newswire
11/21/2024
-
SeekingAlpha.com: All News
11/21/2024
-
TipRanks Financial Blog
11/21/2024
-
The Fly
11/21/2024
-
Globe Newswire
11/5/2024
-
Benzinga
11/5/2024
-
The Fly
11/5/2024
-
The Fly
11/5/2024
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, November 21, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Oct 6 and 10 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
(617) 651-8867
Address
One Kendall Square
Building 1400 West - 3rd Floor
Cambridge, MA 02139
Building 1400 West - 3rd Floor
Cambridge, MA 02139
Country
Year Founded
Business Description
Sector
Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops regulatory RNA-based therapeutics to treat a range of genetic diseases. Its lead product...
more
